140 related articles for article (PubMed ID: 36881054)
1. An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma.
Ishikawa T; Hasegawa I; Hirosawa H; Honmou T; Sakai N; Igarashi T; Yamazaki S; Kobayashi T; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
In Vivo; 2023; 37(2):836-840. PubMed ID: 36881054
[TBL] [Abstract][Full Text] [Related]
2. Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Bockorny B; Bullock AJ; Abrams TA; Faintuch S; Alsop DC; Goldberg SN; Ahmed M; Miksad RA
Dig Dis Sci; 2022 Jul; 67(7):3455-3463. PubMed ID: 34297268
[TBL] [Abstract][Full Text] [Related]
3. Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh Class A Liver function: A Pilot Study.
Wang F; Numata K; Komiyama S; Miwa H; Sugimori K; Ogushi K; Moriya S; Nozaki A; Chuma M; Ruan L; Maeda S
Front Oncol; 2022; 12():843680. PubMed ID: 35600400
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression.
Cao S; Zou Y; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J
Int J Hyperthermia; 2022; 39(1):1-7. PubMed ID: 34937501
[TBL] [Abstract][Full Text] [Related]
5. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis.
Wang X; Liu G; Chen S; Bi H; Xia F; Feng K; Ma K; Ni B
Int J Hyperthermia; 2021 Oct; 38(1):1519-1528. PubMed ID: 34702122
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping.
Iida H; Aihara T; Ikuta S; Yamanaka N
World J Gastroenterol; 2012 Nov; 18(41):5870-8. PubMed ID: 23139602
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis.
Takata K; Tanaka T; Anan A; Fukunaga A; Nagata T; Fukuda H; Yamauchi R; Kunimoto H; Yokoyama K; Morihara D; Takeyama Y; Iwata K; Shakado S; Sakisaka S; Hirai F
Oncology; 2022; 100(6):303-312. PubMed ID: 35114665
[TBL] [Abstract][Full Text] [Related]
9. New next-generation microwave thermosphere ablation for small hepatocellular carcinoma.
Tamai H; Okamura J
Clin Mol Hepatol; 2021 Oct; 27(4):564-574. PubMed ID: 34333957
[TBL] [Abstract][Full Text] [Related]
10. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Hepatocellular Carcinoma Evaluated as Complete Response by Combined Lenvatinib and Radiofrequency Ablation Therapy].
Iwatani Y; Oyama T; Yamano A; Mimura D; Yamano T; Yano Y; Tanaka K
Gan To Kagaku Ryoho; 2023 Jan; 50(1):75-77. PubMed ID: 36759992
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation
Conticchio M; Inchingolo R; Delvecchio A; Laera L; Ratti F; Gelli M; Anelli F; Laurent A; Vitali G; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; di Benedetto F; de'Angelis N; Briceño J; Rampoldi A; Adam R; Cherqui D; Aldrighetti LA; Memeo R
World J Gastroenterol; 2021 May; 27(18):2205-2218. PubMed ID: 34025074
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
15. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
16. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
18. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study.
Yan L; Ren Y; Qian K; Kan X; Zhang H; Chen L; Liang B; Zheng C
BMC Gastroenterol; 2021 Apr; 21(1):182. PubMed ID: 33879085
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.
Wang-Yuan Z; Jiang-Zheng Z; Lu YD; Hao XB; Hong T; Huang F; Lei JH; He ZH; Huang MZ
Int J Hyperthermia; 2016; 32(2):193-8. PubMed ID: 26586093
[TBL] [Abstract][Full Text] [Related]
20. Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma: Suppression of Steam Popping and Its Clinical Implication.
Jeong DY; Kang TW; Min JH; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Han H
Korean J Radiol; 2020 Sep; 21(9):1077-1086. PubMed ID: 32691543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
